First Time Loading...

Allscripts Healthcare Solutions Inc
NASDAQ:MDRX

Watchlist Manager
Allscripts Healthcare Solutions Inc Logo
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Watchlist
Price: 7.5 USD -3.23%
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

160.9m
-15%
Operating Cash Flow
Growth Rates:
1 Year
-
3 Years
+697%
5 Years
-37%
7 Years
-11%
10 Years
-41%
646.4m
+2%
Investing Cash Flow
Growth Rates:
1 Year
-60%
3 Years
+84%
5 Years
-
7 Years
-
10 Years
-
-521m
+2%
Financing Cash Flow
Growth Rates:
1 Year
+60%
3 Years
-48%
5 Years
-
7 Years
-
10 Years
-260%

Cash Flow Statement
Allscripts Healthcare Solutions Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022
Operating Cash Flow
Net Income
49
(1)
(19)
(50)
(108)
(104)
(113)
(108)
(85)
(67)
(56)
(41)
(21)
(2)
10
11
16
3
(8)
(149)
(166)
(154)
(204)
13
6
408
33
(191)
(173)
(183)
(195)
(53)
(46)
(133)
(104)
(74)
(59)
134
144
125
120
Depreciation & Amortization
146
150
157
162
171
179
182
183
179
174
171
169
167
161
154
154
157
136
188
197
207
157
174
188
203
192
177
161
144
207
209
211
209
192
184
177
172
176
146
116
85
Change in Deffered Taxes
9
(13)
(30)
(49)
(45)
(44)
(25)
(9)
(6)
(0)
(5)
(8)
(4)
(2)
(2)
(3)
(9)
(5)
(24)
(26)
(24)
(10)
(14)
(5)
(10)
4
9
2
6
(38)
(40)
(33)
(32)
(3)
(2)
(7)
(8)
(2)
(18)
(3)
(3)
Stock-Based Compensation
38
39
39
40
41
37
39
41
41
39
38
35
34
35
36
37
37
43
41
41
41
39
43
40
41
35
34
36
34
39
37
34
35
34
33
34
34
35
33
33
29
Other Non-Cash Items
46
49
34
46
45
46
59
55
47
46
45
41
40
39
46
51
52
91
53
195
215
197
236
(45)
(66)
(476)
(113)
34
37
78
108
82
82
(11)
(63)
(332)
(342)
(360)
(286)
(50)
(63)
Cash Taxes Paid
0
7
0
0
0
8
0
0
0
7
0
0
0
5
0
0
0
6
0
0
0
7
0
0
0
10
0
0
0
43
0
0
0
77
0
0
0
331
0
0
0
Cash Interest Paid
0
11
0
0
0
13
0
0
0
16
0
0
0
16
0
0
0
15
0
0
0
21
0
0
0
29
0
0
0
20
0
0
0
25
0
0
0
5
0
0
0
Change in Working Capital
22
37
45
30
58
4
(39)
(52)
(65)
(50)
(14)
(7)
(3)
16
21
41
52
19
59
29
25
58
39
54
23
(60)
(91)
(6)
6
(18)
(45)
(140)
(128)
(152)
(114)
(86)
(82)
(24)
3
0
22
Cash from Operating Activities
272
N/A
223
-18%
188
-16%
140
-25%
122
-13%
81
-33%
63
-22%
69
+9%
70
+2%
104
+48%
141
+36%
154
+9%
180
+17%
212
+18%
229
+8%
255
+11%
269
+5%
244
-9%
269
+10%
246
-8%
257
+4%
248
-4%
231
-7%
205
-11%
156
-24%
68
-57%
15
-77%
(1)
N/A
20
N/A
46
+129%
37
-21%
67
+82%
84
+26%
(107)
N/A
(98)
+8%
(322)
-227%
(319)
+1%
(75)
+76%
(11)
+86%
189
N/A
161
-15%
Investing Cash Flow
Capital Expenditures
(120)
(123)
(115)
(123)
(116)
(116)
(113)
(86)
(78)
(67)
(61)
(63)
(65)
(68)
(75)
(90)
(116)
(124)
(164)
(181)
(190)
(157)
(149)
(146)
(138)
(145)
(137)
(124)
(116)
(130)
(128)
(126)
(117)
(105)
(94)
(84)
(79)
(79)
(68)
(60)
(47)
Other Items
0
0
(136)
(136)
(136)
(136)
(6)
(14)
(42)
(42)
(35)
(246)
(218)
(221)
(223)
(930)
(959)
(1 030)
(1 020)
(95)
(120)
(256)
(361)
(186)
(302)
393
502
315
467
(31)
(34)
2
21
1 720
1 725
1 705
1 704
66
31
695
693
Cash from Investing Activities
(120)
N/A
(123)
-3%
(251)
-104%
(259)
-3%
(252)
+3%
(252)
0%
(119)
+53%
(100)
+15%
(119)
-19%
(109)
+9%
(97)
+11%
(309)
-220%
(283)
+8%
(289)
-2%
(298)
-3%
(1 020)
-243%
(1 075)
-5%
(1 154)
-7%
(1 183)
-3%
(276)
+77%
(310)
-12%
(413)
-33%
(510)
-24%
(332)
+35%
(440)
-33%
248
N/A
364
+47%
191
-48%
351
+84%
(161)
N/A
(162)
-1%
(124)
+23%
(96)
+23%
1 615
N/A
1 631
+1%
1 621
-1%
1 625
+0%
(12)
N/A
(37)
-207%
635
N/A
646
+2%
Financing Cash Flow
Net Issuance of Common Stock
(216)
(220)
(214)
62
64
63
57
4
2
2
(0)
101
102
104
66
284
264
(121)
250
(81)
(62)
(11)
(68)
(100)
(99)
(138)
(145)
(101)
(149)
(112)
(56)
(56)
(55)
(335)
(325)
(634)
(589)
(417)
(467)
(252)
(285)
Net Issuance of Debt
80
72
198
46
73
105
(12)
3
32
5
14
101
66
45
22
503
535
95
679
117
156
186
337
236
349
(284)
(310)
(167)
(278)
272
286
211
183
(765)
(894)
(624)
(710)
175
175
(253)
(203)
Other
(9)
(7)
(5)
(37)
(37)
(36)
(38)
(8)
(8)
(10)
(11)
(9)
(9)
(6)
(8)
(8)
(7)
892
(9)
(7)
(9)
24
18
11
12
128
80
85
75
(93)
(40)
(41)
(31)
(10)
(12)
(17)
(17)
(16)
(22)
(28)
(33)
Cash from Financing Activities
(145)
N/A
(155)
-7%
(20)
+87%
71
N/A
99
+39%
132
+33%
7
-95%
(1)
N/A
26
N/A
(4)
N/A
4
N/A
193
+5 261%
159
-18%
142
-11%
80
-44%
779
+870%
792
+2%
865
+9%
920
+6%
29
-97%
85
+198%
199
+134%
287
+44%
147
-49%
262
+79%
(293)
N/A
(375)
-28%
(183)
+51%
(352)
-92%
67
N/A
190
+183%
115
-40%
97
-15%
(1 110)
N/A
(1 231)
-11%
(1 275)
-4%
(1 315)
-3%
(259)
+80%
(314)
-21%
(533)
-69%
(521)
+2%
Change in Cash
Effect of Foreign Exchange Rates
2
2
0
(1)
(2)
(2)
(2)
0
0
(0)
(1)
(1)
(2)
(1)
(0)
(1)
0
(1)
(1)
(0)
0
1
1
0
(0)
(1)
(1)
(0)
(0)
0
(1)
(0)
0
1
2
2
1
(1)
(1)
(1)
(1)
Net Change in Cash
9
N/A
(54)
N/A
(83)
-55%
(48)
+42%
(33)
+32%
(41)
-25%
(51)
-24%
(33)
+36%
(23)
+28%
(10)
+58%
47
N/A
37
-20%
54
+45%
64
+18%
12
-82%
14
+22%
(14)
N/A
(45)
-224%
5
N/A
(1)
N/A
32
N/A
34
+7%
8
-77%
20
+153%
(21)
N/A
22
N/A
4
-82%
7
+80%
19
+154%
(47)
N/A
64
N/A
57
-11%
86
+51%
400
+364%
303
-24%
26
-91%
(9)
N/A
(347)
-3 889%
(363)
-5%
290
N/A
286
-2%
Free Cash Flow
Free Cash Flow
152
N/A
100
-34%
73
-27%
18
-76%
6
-67%
(35)
N/A
(50)
-42%
(18)
+64%
(8)
+55%
36
N/A
79
+118%
91
+15%
115
+26%
144
+25%
154
+7%
165
+7%
153
-7%
120
-22%
105
-12%
65
-38%
67
+2%
91
+36%
81
-10%
59
-28%
19
-68%
(77)
N/A
(122)
-59%
(124)
-2%
(96)
+23%
(84)
+13%
(92)
-9%
(59)
+36%
(32)
+45%
(212)
-555%
(193)
+9%
(406)
-111%
(398)
+2%
(154)
+61%
(79)
+49%
129
N/A
114
-11%

See Also

Summary
MDRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDRX stock valuation using valuation multiples.
Wall Street Estimates
MDRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.